We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

The government has canceled nearly $500 million in research grants into the revolutionary technology, which experts believe ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

HHS canceled federal funding for mRNA vaccine development. Experts said this could affect our preparedness for future ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

The Trump Administration said this week it is pulling half a billion dollars from U.S. government-funded research projects to ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

In March 2022, the NIAID announced that they were launching a phase 1 trial of three HIV vaccines utilizing the same mRNA technology that had been used in certain approved COVID-19 vaccines.⁶ ...